News

Clínic Barcelona

Research November 19 2024

Nine researchers from the Clínic-IDIBAPS among the most highly cited researchers according to Clarivate Analytics

Clarivate Analytics has published its ranking of the most cited researchers in the world, the Highly Cited Researchers, which identifies the most inf1

Clínic Barcelona

Research September 19 2024

Clínic-IDIBAPS researchers present around 40 studies at ESMO 2024

One of the highlights of the Clínic-IDIBAPS participation in the European Society for Medical Oncology (ESMO) 2024 Congress was Dr. Josep M. Llovet’s1

Clínic Barcelona

Research June 19 2024

IDIBAPS leads an 8-million-euro immunotherapy project granted by the Spanish Association Against Cancer to improve survival in hepatocellular carcinoma

Dr. Llovet (Clínic-IDIBAPS) and Dr. Bustelo (CSIC-University of Salamanca) coordinate the ASPIRE-AECC project, which includes 15 hospitals to conduct1

Clínic Barcelona

Research March 14 2024

Hospital Clínic-IDIBAPS researchers review adjuvant treatment with immunotherapy and vaccines for liver cancer

Researchers from the Hospital Clínic-IDIBAPS have published a review in Nature Reviews Clinical Oncology about the adjuvant and neoadjuvant treatment1

Clínic Barcelona

Research January 18 2024

The European Union launches the THRIVE project to improve the prognosis of children and adults with liver cancer

Endowed with €12 million, the project is coordinated by Prof. Josep M. Llovet, the head of the IDIBAPS group Translational Research in Hepatic Oncolo1

page1 , current page.
page2
page3
page4
page5

News

Nine researchers from the Clínic-IDIBAPS among the most highly cited researchers according to Clarivate Analytics

Clínic-IDIBAPS researchers present around 40 studies at ESMO 2024

IDIBAPS leads an 8-million-euro immunotherapy project granted by the Spanish Association Against Cancer to improve survival in hepatocellular carcinoma

Hospital Clínic-IDIBAPS researchers review adjuvant treatment with immunotherapy and vaccines for liver cancer

The European Union launches the THRIVE project to improve the prognosis of children and adults with liver cancer

navigation between pages below